Alan Tseng News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Golden Biotechnology Corp (GBC, 國鼎) plans to apply for emergency use authorization in the US for its experimental COVID-19 drug after positive results in its phase 2 clinical trials, the company said. GBC on Wednesday announced some of the results from randomized, double-blind and placebo-controlled studies in phase 2 clinical trials of its COVID-19 oral drug antroquinonol, dubbed Hocena, for the treatment of people hospitalized with mild-to-moderate COVID-19 symptoms. In the trials, 97.9 percent of people recovered by the 14th day after being given the drug and all participants recovered ...

By Kao Shih-ching / Staff reporterGolden Biotechnology Corp （GBC, 國鼎） plans to apply for emergency use authorization in the US for its experimental COVID-19 drug after positive results in its phase 2 clinical trials, the company said.

Shares of Apple Inc. (NASDAQ: AAPL) were trading lower by around 1.50 percent early Thursday morning in reaction to a concerning report from Taiwan's Economic Daily News relating to iPhone 8 production. Apple may have requested a 50 percent cut in orders for the iPhone 8 possibly due to poor... Read More...